Observational studyMedicine2021

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.

Hèctor Corominas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.